Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome

Respiration

Volumn 87, Issue 1, 2014, Pages 63-74

  Fu, Juan Juan ^a,c   Gibson, Peter G ^a,c,d   Simpson, Jodie L ^a,c   McDonald, Vanessa M ^a,b,c  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

^d WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Asthma; Asthma COPD overlap; Chronic obstructive pulmonary disease; Longitudinal changes; Multidimensional assessment; Obstructive airway disease

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 6; SALBUTAMOL; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMORBIDITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SPIROMETRY; SYNDROME; 6 MINUTE WALK DISTANCE; ASTHMA COPD OVERLAP SYNDROME; COHORT ANALYSIS; CORTICOSTEROID THERAPY; DETERIORATION; DISEASE COURSE; EOSINOPHIL COUNT; EXERCISE; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITALIZATION; LUNG FUNCTION; NEUTROPHIL COUNT; OBSTRUCTIVE AIRWAY DISEASE; PHENOTYPE; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE ASSESSMENT; ST. GEORGE RESPIRATORY QUESTIONNAIRE;

AGED; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; SYNDROME;

EID: 84893317803     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000352053     Document Type: Article

References (51)

1. Gibson PG, McDonald VM, Marks GB: Asthma in older adults. Lancet 2010; 376: 803-813.
2. McDonald VM, Higgins I, Gibson PG: Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: Diagnostic and therapeutic challenges. Drugs Aging 2013; 30: 1-17.
3. Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. Updated 2012. http://www.ginasthma. com.
4. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
5. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, Van Der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
6. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management and Prevention of COPD. Updated 2011. www.goldcopd.com.
7. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB: The proportional Venn diagram of obstructive lung disease: Two approximations from the United States and the United Kingdom. Chest 2003; 124: 474-481.
8. Al-Kassimi FA, Abba AA, Al-Hajjaj MS, Alhamad EH, Raddaoui E, Shaikh SA: Asthma masquerading as chronic obstructive pulmonary disease: A study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease. Respiration 2011; 82: 19-27.
9. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, Hansell AL, Nowitz MR, McNaughton AA, Soriano JB, Beasley RW: Proportional classifications of COPD phenotypes. Thorax 2008; 63: 761-767.
10. Gibson PG, Simpson JL: The overlap syndrome of asthma and COPD: What are its features and how important is it Thorax 2009; 64: 728-735.
11. Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, Romagnoli M, Caramori G, Saetta M, Fabbri LM, Papi A: Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year followup. J Allergy Clin Immunol 2010; 125: 830-837.
12. Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP: The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12: 127.
13. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, Haahtela T, Laitinen T: Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48: 279-285.
14. Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aguero R, Baloira A, Carrizo S, Esteban C, Galdiz JB, Gonzalez MC, Miravitlles M, Monso E, Montemayor T, Morera J, Ortega F, Peces-Barba G, Puente L, Rodriguez JM, Sala E, Sauleda J, Soriano JB, Viejo JL: Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012; 48: 331-337.
15. Kim TB, Oh YM, Chang YS, Cho YS, Jang AS, Cho SH, Choi BW, Lee SD, Moon HB: The reality of an intermediate type between asthma and COPD in practice. Respir Care 2012; 57: 1248-1253.
16. Celli BR, Cote CG, Marin JM, Casanova C, Montes De Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
17. McDonald VM, Simpson JL, Higgins I, Gibson PG: Multidimensional assessment of older people with asthma and COPD: Clinical management and health status. Age Ageing 2010; 40: 42-49.
18. Dreborg S: Bronchial hyper-reactivity and skin sensitivity. Clin Exp Allergy 1991; 21: 529.
19. Gibson PG, Wlodarczyk JW, Hensley MJ, Gleeson M, Henry RL, Cripps AW, Clancy RL: Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998; 158: 36-41.
20. Sato S, Nishimura K, Koyama H, Tsukino M, Oga T, Hajiro T, Mishima M: Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest 2003; 124: 1749-1754.
21. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. Georges Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
23. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
24. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B: The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976; 113: 587-600.
25. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117. 26 Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PMA, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI: Changes in forced expiratory volume in
26. second over time in COPD. N Engl J Med 2011; 365: 1184-1192.
27. Anthonisen NR, Wright EC, Hodgkin JE: Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20.
28. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC: Lung function and mortality in the United States: Data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58: 388-393.
29. Berry CE, Wise RA: Mortality in COPD: Causes, risk factors, and prevention. COPD 2010; 7: 375-382.
30. Oga T, Tsukino M, Hajiro T, Ikeda A, Koyama H, Mishima M, Chin K, Nishimura K: Multidimensional analyses of long-term clinical courses of asthma and chronic obstructive pulmonary disease. Allergol Int 2010; 59: 257-265.
31. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Koyama H, Mishima M: Longitudinal changes in patient vs. physician-based outcome measures did not significantly correlate in asthma. J Clin Epidemiol 2005; 58: 532-539.
32. Oga T, Nishimura K, Tsukino M, Hajiro T, Sato S, Ikeda A, Hamadas C, Mishima M: Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease. Qual Life Res 2004; 13: 1109-1116.
33. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Exercise capacity deterioration in patients with COPD: Longitudinal evaluation over years. Chest 2005; 128: 62-69.
34. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW: Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-664.
35. Anthonisen NR, Lindgren PG, Tashkin DP, Kanner RE, Scanlon PD, Connett JE, Lung Health Study Research Group: Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 2005; 26: 45-51.
36. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS: Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003; 58: 322-327.
37. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S: Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 44-52.
38. Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA: Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 1301-1306.
39. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM: Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-338.
40. Casanova C, De Torres JP, Aguirre-Jaime A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR: The progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the BODE cohort. Am J Respir Crit Care Med 2011; 184: 1015-1021.
41. Casanova C, Cote CG, Marin JM, De Torres JP, Aguirre-Jaime A, Mendez R, Dordelly L, Celli BR: The 6-min walking distance: Longterm follow up in patients with COPD. Eur Respir J 2007; 29: 535-540.
42. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF: Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010; 91: 221-225.
43. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F: The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790.
44. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH: Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
45. Jones PW: St. Georges Respiratory Questionnaire: MCID. COPD 2005; 2: 75-79.
46. Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, Jenkins M, Lloyd A, Rugman P, Newbold P, Brightling CE: Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration 2012; 83: 36-44.
47. Kroegel C, Bakakos P: The inflammatory effector cell pattern in asthma and chronic obstructive pulmonary disease-what is it good for Respiration 2012; 83: 17-19.
48. Joos GF, OConnor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lotvall J, Magnussen H, Polosa R, Postma DS, Riedler J: Indirect airway challenges. Eur Respir J 2003; 21: 1050-1068.
49. Van Schoor J, Pauwels R, Joos G: Indirect bronchial hyper-responsiveness: The coming of age of a specific group of bronchial challenges. Clin Exp Allergy 2005; 35: 250-261.
50. Cockcroft D, Davis B: Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol 2009; 103: 363-369, quiz 369-372, 400.
51. Silva GE, Sherrill DL, Guerra S, Barbee RA: Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126: 59-65.